Up Next in 340B
Your Exclusive Client Update
NEWSLETTER
Date: September 2025
By: RxX Consulting
This Week’s Highlights
Bausch listed as a terminated labeler on Medicaid.gov - an indication of intent to withdraw from the Medicaid Drug Rebate Program
New Exelixis Policy released
340B News & Updates
📄 Change to Exelixis’ 340B Integrity Initiative means major protocol changes Effective October 1, 2025, covered entities may no longer utilize contract pharmacy “bill to/ship to” arrangements. . .
📄 Mounting pressure on new 340B Pilot HHS’ new pilot is under scrutiny
RxX Perspective
“Let’s be clear, the gap between what anyone pays and what a drug truly costs is a total unknown driven by drug manufacturers’ own opaque pricing practices—not by . . . . . .”
What Working with Rx|X Means
Rx|X is built on higher standards.
While HRSA audits don’t require Yellow Book standards, Rx|X voluntary incorporates them. This means:
Stronger planning and documentation
Clear, transparent reporting
Evidence-driven conclusions
Learn about Rx|X’s new tool Avanti340B, a major driver in this standard.
What’s Coming Up
📅 September 12, 2025 – Webinar: Breaking Down HRSA’s New Data Request List for FY26
📅 September 29-October 1st, 2025 - HOSP Conference in DC
📅 TBD October 2025 – 340B Legislative Update with Felicity Homsted
Need help?
If any additional team members would like to receive these updates directly, please have them either fill out the form using the button below or email us directly at info@rxxconsulting.com.